Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ICCM is 22.06M, and currently, short sellers hold a 6.66% ratio of that float. The average trading volume of ICCM on December 18, 2024 was 719.27K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ICCM) stock’s latest price update
Icecure Medical Ltd (NASDAQ: ICCM)’s stock price has soared by 1.85 in relation to previous closing price of 1.08. Nevertheless, the company has seen a gain of 31.74% in its stock price over the last five trading days. prnewswire.com reported 2024-12-16 that ICE3 trial results presented by ICE3 Co-Principal Investigator Dr. Kenneth Tomkovich FDA Advisory Panel voted in favor of IceCure’s ProSense® cryoablation benefit-risk profile in early-stage low risk breast cancer in Nov. 2025 FDA’s marketing authorization decision expected in Q1, 2025 CAESAREA, Israel, Dec. 16, 2024 /PRNewswire/ — IceCure Medical Ltd. (Nasdaq: ICCM) (“IceCure”, “IceCure Medical” or the “Company”), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that data from its ICE3 trial of ProSense’s® in early-stage breast cancer were presented at the Radiological Society of North America’s 2024 Annual Meeting on December 5, 2024 in Chicago, IL.
ICCM’s Market Performance
Icecure Medical Ltd (ICCM) has experienced a 31.74% rise in stock performance for the past week, with a 83.33% rise in the past month, and a 69.23% rise in the past quarter. The volatility ratio for the week is 11.79%, and the volatility levels for the past 30 days are at 9.66% for ICCM. The simple moving average for the last 20 days is 29.93% for ICCM’s stock, with a simple moving average of 28.88% for the last 200 days.
ICCM Trading at 51.89% from the 50-Day Moving Average
After a stumble in the market that brought ICCM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.94% of loss for the given period.
Volatility was left at 9.66%, however, over the last 30 days, the volatility rate increased by 11.79%, as shares surge +85.31% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +90.85% upper at present.
During the last 5 trading sessions, ICCM rose by +35.33%, which changed the moving average for the period of 200-days by -10.32% in comparison to the 20-day moving average, which settled at $0.8481. In addition, Icecure Medical Ltd saw 2.80% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ICCM
Current profitability levels for the company are sitting at:
- -3.95 for the present operating margin
- 0.44 for the gross margin
The net margin for Icecure Medical Ltd stands at -3.74. The total capital return value is set at -1.43. Equity return is now at value -111.35, with -79.74 for asset returns.
Currently, EBITDA for the company is -15.25 million with net debt to EBITDA at 0.71. When we switch over and look at the enterprise to sales, we see a ratio of 13.42. The receivables turnover for the company is 5.43for trailing twelve months and the total asset turnover is 0.24. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.67.
Conclusion
To put it simply, Icecure Medical Ltd (ICCM) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
